Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    March 07-08, 2024

    14th World Glycobiology Congress

    Toronto, Canada
    March 28-29, 2024

    6th International Conference on Biochemistry

    Dubai, UAE
    May 16-17, 2024

    30th Asia Pacific Biotechnology Congress

    Rome, Italy
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France

    Metabolomics in detection of Chemotoxicity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in